Novo Nordisk Foundation Pumps €85M into Carbon Capture Research
As pressure mounts to tackle climate change, the Danish Novo Nordisk Foundation has granted €84.7M…
01/10/2021 - 6 minutes
Anita Chakraverty
Anita Chakraverty is a freelance medical journalist and science communicator. Outside work, she enjoys a good movie, long walks in the local woods, and trying to get into pretzel-like yoga poses.
UK Startup Surfs Investment Wave in Microbiome with €18M Series A
As increasing attention turns to microbiome-based therapeutics, the Scottish biotech Enterobiotix has closed a Series…
15/09/2021 - 4 minutes
European Biotechs Fire up Deals to Develop Parkinson’s Treatments
Last month, European biotechs Ipsen and AC Immune announced multi-million euro deals to acquire or…
12/08/2021 - 4 minutes
Artios’ €129M Series C Pushes Limits of DNA Repair in Cancer
The UK firm Artios Pharma raised a huge Series C round last week in one…
06/08/2021 - 4 minutes
British Diagnostics Biotech Becomes Social Enterprise After Acquisition
UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by…
30/07/2021 - 4 minutes
Multi-Million UK Life Sciences Initiative Welcomed By VC Firms
Biotech venture capital firms across Europe have warmly received the launch of a €235M (£200M)…
16/07/2021 - 4 minutes
Sofinnova Taps into Italian Gene Therapy with Three Seed Financings
The French investor Sofinnova Partners has injected a total of €6M into three Italian gene…
12/07/2021 - 5 minutes
Poxel’s Diabetes Drug Wins Japan Nod, But Competition Remains Fierce
As French biotech Poxel marks the first market approval of its oral type 2 diabetes…
02/07/2021 - 5 minutes
Patent Waiver on Covid-19 Vaccines Splits Opinions in Biotech Industry
Attempts to increase global Covid-19 vaccine coverage with a temporary patent waiver have been met…
15/06/2021 - 5 minutes
EU Approves Edible Insects for Humans but Roadblocks Remain
Europe is seeing a surge of interest in edible insect farming after an EU vote…
20/05/2021 - 6 minutes
Bluebird Bio Withdrawal Raises Gene Therapy Doubts in Europe
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo…
04/05/2021 - 5 minutes
Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions
The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in…
20/04/2021 - 5 minutes
